And we are off! Very interested to track the recruitment rate given patients are apparently banked up.
Bioshares included FTT in their top 6 picks for 2017 in their latest newsletter. Last year they achieved an 83% return.
Picked up a few more today. GLTA
Ann: Phase II Clinical Trial - First Patient In, page-2
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DLM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| DLM (ASX) Chart |
Day chart unavailable